Results 231 to 240 of about 169,700 (260)

Prospects and advances in hormonal immunomodulatory therapy

Baillière's Clinical Rheumatology, 1996
Modulation of the immune network through the hormonal system is an exciting emerging concept. It results from a decade of experimental research obtained on rodents. Unfortunately, the therapeutic response on NZB/NZW F1 mice with murine lupus or in adjuvant induced arthritis are not transferable to man.
C, Jorgensen, J, Sany
openaire   +2 more sources

Developments in systemic immunomodulatory therapy for psoriasis

Current Opinion in Pharmacology, 2007
Psoriasis is an inflammatory skin condition that can be accompanied by joint disease. Pre-biological and biological systemic therapies are effective. Dermatologists have used systemic immunomodulators including methotrexate to treat moderate-to-severe disease for over 30 years.
Emily M, Berger, Alice B, Gottlieb
openaire   +2 more sources

Biologic Immunomodulatory Therapies in the Vasculitic Diseases

Seminars in Respiratory and Critical Care Medicine, 2004
The expanding range of biologic agents capable of modulating the immune response has opened up a new realm for therapeutic exploration in the vasculitic diseases. Partnered with increasing knowledge regarding the mechanisms of vascular inflammation, these agents have raised the question as to whether it may be possible to treat systemic vasculitis ...
openaire   +2 more sources

Immunomodulatory Approaches to the Therapy of AIDS

Clinical Immunotherapeutics, 1996
Immune-based therapies are being explored on the presumption that host response to HIV is central to the pathogenesis and progression of HIV infection. Specific immune responses in most individuals serve to limit the acute stage of infection and induce a more chronic form of viral infection.
John L. Fahey, Ronald Mitsuyasu
openaire   +1 more source

Contemporary Immunomodulatory Therapy for Multiple Sclerosis

Journal of Neuro-Ophthalmology, 2001
Multiple sclerosis (MS) is no longer considered an unmanageable disease. Five drugs have obtained regulatory approval to safely and effectively modify the course of MS. Three preparations of interferon beta-Avonex (interferon beta-1a), Betaseron (interferon beta-1b), and Rebif (interferon beta 1a)-have shown efficacy in relapsing-remitting MS and show ...
openaire   +2 more sources

Immunomodulatory Therapies

2021
David E. Thurston, Ilona Pysz
openaire   +1 more source

Immunomodulatory agents for prophylaxis and therapy of infections

International Journal of Antimicrobial Agents, 2000
The advent of the antibiotic era ushered in a shift towards non-pathogen-specific therapy of infectious diseases. This led to an overt emphasis on targeting microbial pathogens while strategies directed towards enhancing host immunity were neglected. In an effort to decrease sole reliance on antimicrobials, the time has come for a critical reappraisal ...
openaire   +2 more sources

SPIRONOLACTONE AS IMMUNOMODULATORY THERAPY IN ALDOSTERONISM.

Journal of Investigative Medicine, 2001
A. Malhotra, I. C. Gerling, Y. Sun, K. J. Warrington, A. E. Postlethwaite, K. T. Weber   +5 more
openaire   +1 more source

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy

Frontiers in Immunology, 2022
Huifang Liang, Zhiyong Huang, Erlei Zhang   +2 more
exaly  

A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis

Ophthalmology Science, 2022
Kerry Casey, H Nida Sen
exaly